Maxlinear Inc
XBER:JMX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Maxlinear Inc
XBER:JMX
|
US |
|
Thermax Limited
NSE:THERMAX
|
IN |
|
F
|
Franchetti SpA
F:D0E
|
IT |
|
Gurit Holding AG
F:GVM0
|
CH |
|
R
|
Range Resources Corp
SWB:RAX
|
US |
|
TechPrecision Corp
NASDAQ:TPCS
|
US |
|
WuXi Biologics (Cayman) Inc
F:1FW2
|
CN |
|
N
|
NXP Semiconductors NV
XMUN:VNX
|
NL |
|
Fresenius Medical Care AG & Co KGaA
NYSE:FMS
|
DE |
|
New Jersey Resources Corp
F:NJ1
|
US |
|
B
|
Boston Beer Company Inc
XBER:BBEA
|
US |
|
C
|
Commerzbank AG
SWB:ZZMS
|
DE |
Wall St Price Targets
JMX Price Targets Summary
Maxlinear Inc
According to Wall Street analysts, the average 1-year price target for
JMX is 7.756 EUR with a low forecast of 4.378 EUR and a high forecast of 12.643 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is JMX's stock price target?
Price Target
7.756
EUR
According to Wall Street analysts, the average 1-year price target for
JMX is 7.756 EUR with a low forecast of 4.378 EUR and a high forecast of 12.643 EUR.
What is the Revenue forecast for Maxlinear Inc?
Projected CAGR
23%
Over the last 13 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 3 years is 23%.